Loading...
XLON
CIZ
Market cap13mUSD
Jul 09, Last price  
2.35GBP
1D
-6.00%
1Q
0.00%
IPO
-74.93%
Name

Cizzle Biotechnology Holdings PLC

Chart & Performance

D1W1MN
XLON:CIZ chart
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
74.05%
Rev. gr., 5y
-55.19%
Revenues
0k
222,000307,0001,628,0001,561,0002,720,0006,061,0008,701,0009,423,0007,188,0006,901,0005,319,0004,547,00074,0000000000
Net income
-691k
L+31,802.12%
-1,453,000-1,865,000-1,342,000-369,000-886,000-1,024,000-780,000-651,000-1,332,000-2,767,000000-830,000-306,000-3,920,000-910,000-1,717-2,166-691,000
CFO
-496k
L+38.55%
-1,097,000-2,095,000-1,549,000-150,000-305,000-1,510,000-145,000-678,000-526,000-570,000186,000-190,000-513,000-7,072-294,000-1,009,000-872,000-639,000-358,000-496,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Cizzle Biotechnology Holdings Plc specializes in developing an advanced immunoassay diagnostic test. This innovative tool aims to identify the CIZ1B biomarker, facilitating the early detection of lung cancer. The company, previously known as Cizzle Biotechnology Limited, officially changed its corporate identity to Cizzle Biotechnology Holdings Plc in May 2021. Its main operational base is situated in London, United Kingdom.
URL
https://cizzlebiotechnology.com/
IPO date
May 23, 2007
Employees
4
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT